Neuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and Pitfalls
Open Access
- 1 October 2015
- journal article
- review article
- Published by Elsevier BV in SLAS Discovery
- Vol. 20 (9), 1055-1073
- https://doi.org/10.1177/1087057115601677
Abstract
No abstract availableThis publication has 141 references indexed in Scilit:
- Transient outward current (Ito) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndromeHeart Rhythm, 2011
- Molecular determinants of cardiac transient outward potassium current (Ito) expression and regulationJournal of Molecular and Cellular Cardiology, 2010
- Epilepsy, Ataxia, Sensorineural Deafness, Tubulopathy, andKCNJ10MutationsThe New England Journal of Medicine, 2009
- Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10Proceedings of the National Academy of Sciences of the United States of America, 2009
- A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndromeCardiovascular Research, 2008
- Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillationHeart Rhythm, 2008
- KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillationNature Clinical Practice Cardiovascular Medicine, 2007
- Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorderNature Genetics, 2005
- Mapping the BKCa Channel's “Ca2+ Bowl”The Journal of general physiology, 2004
- ATP-sensitive K + channels and insulin secretion: their role in health and diseaseDiabetologia, 1999